SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers

Por um escritor misterioso
Last updated 24 março 2025
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers designed to knockdown human SUMO-2/3 gene expression. Cited in 5 publications
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
Release of human cytomegalovirus from latency by a KAP1/TRIM28
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
MBD1 Gene - GeneCards, MBD1 Protein
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
Monoubiquitination of ASXLs controls the deubiquitinase activity
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
PDF) MicroRNA-194 Inhibition Promotes SUMO-2-Dependent Neuro
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
PDF) Systemic Delivery of shRNA by AAV9 Provides Highly Efficient
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
Transcription factor AP-2α activates RNA polymerase III–directed
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
Inhibiting ubiquitination causes an accumulation of SUMOylated
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
SENP6 Gene - GeneCards, SENP6 Protein
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
RNF4 promotes tumorigenesis, therapy resistance of
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
WO2021165484A1 - Depletion of ext1 expression and/or activity
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
CCT complex restricts neuropathogenic protein aggregation via
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
The deubiquitinase USP36 promotes snoRNP group SUMOylation and is
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
PDF) MicroRNA-194 Inhibition Promotes SUMO-2-Dependent Neuro
SUMO-2/3 siRNA (h), shRNA and Lentiviral Particle Gene Silencers
Viruses, Free Full-Text

© 2014-2025 startwindsor.com. All rights reserved.